Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Accidental nicotinic acid derivative poisoning |
Causative agent (attribute) |
False |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Intentional nicotinic acid derivative poisoning |
Causative agent (attribute) |
False |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nicotinic acid derivative poisoning of undetermined intent |
Causative agent (attribute) |
False |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nicotinic acid adverse reaction |
Causative agent (attribute) |
True |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Nicotinic acid derivative overdose |
Causative agent (attribute) |
False |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Accidental nicotinic acid derivative overdose |
Causative agent (attribute) |
False |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Intentional nicotinic acid derivative overdose |
Causative agent (attribute) |
False |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Nicotinic acid derivative overdose of undetermined intent |
Causative agent (attribute) |
False |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Nicotinic acid 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nicotinamide 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Niacinamide preparation (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing nicotinic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Niacinamide [skin] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nicotinic acid 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nicotinic acid 750 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely nicotinic acid 1 gram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lovastatin 20 mg and nicotinic acid 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely lovastatin 20 milligram and nicotinic acid 750 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lovastatin 20 mg and nicotinic acid 1 g oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing lovastatin and nicotinic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely nicotinamide 40 milligram/1 gram conventional release cutaneous gel (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nicotinic acid 375mg m/r tablet and nicotinic acid 500mg m/r tablet and nicotinic acid 750mg m/r tablet starter pack |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nicotinic acid 500mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nicotinic acid 750mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nicotinic acid 1000mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nicotinic acid compound |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Accidental nicotinic acid derivative poisoning |
Causative agent (attribute) |
False |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Intentional nicotinic acid derivative poisoning |
Causative agent (attribute) |
False |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to nicotinic acid (finding) |
Causative agent (attribute) |
False |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Poisoning by nicotinic acid derivative |
Causative agent (attribute) |
False |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Niacin measurement |
Component |
True |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Serum nicotinic acid measurement |
Component |
False |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely nicotinic acid 250 milligram/1 each prolonged-release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nicotinic acid 250 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lovastatin 40 mg and nicotinic acid 1 g oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nicotinic acid 1 g and simvastatin 20 mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely nicotinic acid 500 milligram and simvastatin 20 milligram/1 each prolonged-release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nicotinic acid 750 mg and simvastatin 20 mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing nicotinic acid and simvastatin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to nicotinic acid (finding) |
Causative agent (attribute) |
True |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Nicotinic acid 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Nicotinic acid 50 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Nicotinic acid 750 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Nicotinic acid 750 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely nicotinic acid 1 gram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely nicotinic acid 1 gram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Nicotinic acid 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Nicotinic acid 500 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lovastatin 20 mg and nicotinic acid 500 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely lovastatin 20 milligram and nicotinic acid 750 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely lovastatin 20 milligram and nicotinic acid 750 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lovastatin 20 mg and nicotinic acid 1 g oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lovastatin 20 mg and nicotinic acid 1 g oral tablet |
Has basis of strength substance (attribute) |
True |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lovastatin 40 mg and nicotinic acid 1 g oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lovastatin 40 mg and nicotinic acid 1 g oral tablet |
Has basis of strength substance (attribute) |
True |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Nicotinic acid 250 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Nicotinic acid 250 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lovastatin 20 mg and nicotinic acid 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Lovastatin 20 mg and nicotinic acid 500 mg oral tablet |
Has basis of strength substance (attribute) |
False |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Niacin supplement therapy (regime/therapy) |
Direct substance |
False |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Increase in niacin content of the diet compared to the assessed baseline intake of niacin for the individual. |
Direct substance |
True |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Niacin modified diet (regime/therapy) |
Direct substance |
True |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ethylnicotinamide (substance) |
Is modification of (attribute) |
True |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Decreased niacin diet (regime/therapy) |
Direct substance |
True |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
nicotinamide |
Is modification of (attribute) |
True |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hexyl nicotinate (substance) |
Is modification of (attribute) |
True |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Xantinol nicotinate |
Is modification of (attribute) |
True |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nicotinic acid 375mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely nicotinic acid 1 gram/1 each prolonged-release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely nicotinic acid 1 gram/1 each prolonged-release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Nicotinic acid 750 mg prolonged-release oral tablet |
Has basis of strength substance (attribute) |
True |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Nicotinic acid 750 mg prolonged-release oral tablet |
Has precise active ingredient |
True |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely nicotinic acid 500 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely nicotinic acid 500 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing nicotinic acid in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lovastatin 40 mg and nicotinic acid 1 g oral tablet |
Has precise active ingredient |
True |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Nicotinic acid 750 mg oral tablet |
Has precise active ingredient |
True |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Nicotinic acid 50 mg oral tablet |
Has precise active ingredient |
True |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lovastatin 20 mg and nicotinic acid 500 mg oral tablet |
Has precise active ingredient |
True |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely lovastatin 20 milligram and nicotinic acid 750 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Nicotinic acid 250 mg oral tablet |
Has precise active ingredient |
True |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Nicotinic acid 500 mg oral tablet |
Has precise active ingredient |
True |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely nicotinic acid 1 gram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lovastatin 20 mg and nicotinic acid 1 g oral tablet |
Has precise active ingredient |
True |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Lovastatin- and nicotinic acid-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing nicotinic acid in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Morniflumate (substance) |
Is modification of (attribute) |
False |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nicotinic acid only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only nicotinic acid and simvastatin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only lovastatin and nicotinic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Nicotinic acid only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Nicotinic acid only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only lovastatin and nicotinic acid in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Nicotinic acid 1 g and simvastatin 20 mg prolonged-release oral tablet |
Has precise active ingredient |
True |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Nicotinic acid 1 g and simvastatin 20 mg prolonged-release oral tablet |
Has basis of strength substance (attribute) |
True |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Nicotinic acid 750 mg and simvastatin 20 mg prolonged-release oral tablet |
Has precise active ingredient |
True |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Nicotinic acid 750 mg and simvastatin 20 mg prolonged-release oral tablet |
Has basis of strength substance (attribute) |
True |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely nicotinic acid 500 milligram and simvastatin 20 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely nicotinic acid 500 milligram and simvastatin 20 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely nicotinic acid 250 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely nicotinic acid 250 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Nicotinic acid (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |